Evidence map›Paper›PMID 17959600›Full record

ArticleThe Journal of biological chemistry2008

Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans.

Gawain McColl, David W Killilea, Alan E Hubbard, Maithili C Vantipalli, Simon Melov, Gordon J Lithgow

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 201 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Pharmacology of Aging:Aging biology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gawain McCollBuck Institute for Age Research, Novato, California 94945, the. Electronic address: gmccoll@mhri.edu.au.
David W KillileaNutrition and Metabolism Center, Children's Hospital Oakland Research Institute, Oakland, California 94609, and the.
Alan E HubbardSchool of Public Health, University of California, Berkeley California 94720.
Maithili C VantipalliBuck Institute for Age Research, Novato, California 94945, the.
Simon MelovBuck Institute for Age Research, Novato, California 94945, the.
Gordon J LithgowBuck Institute for Age Research, Novato, California 94945, the.
Buck Institute for Research on Aging · USUniversity of California, Berkeley · US

Funding

Core--RESEARCH DEVELOPMENTP30AG025708 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI CAMPISI, JUDITH · 2005 to 2009
$3.7M
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATIONR01AG018679 · NIA · BUCK INSTITUTE FOR AGE RESEARCH · PI MELOV, SIMON · 2000 to 2004
$2.5M
Lifespan determination and stress response in C. elegansR01AG021069 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI LITHGOW, GORDON J. · 2002 to 2006
$2.4M
Comparative Biology of p53, Checkpoint and LongevityR01AG022868 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI LITHGOW, GORDON J. · 2003 to 2007
$1.9M
Comparative Functional Genomics of Longevity AssuranceR01AG024385 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI MELOV, SIMON · 2004 to 2006
$1.2M
C. elegans, Aging and High Throughput Screening (RMI)R03NS050789 · NINDS · BUCK INSTITUTE FOR AGE RESEARCH · PI LITHGOW, GORDON J. · 2004 to 2004
$97k
NIA NIH HHS AG 21069NIA NIH HHS AG 22868NIA NIH HHS P30 AG 025708NIA NIH HHS P30 AG025708NIA NIH HHS R01 AG018679NIA NIH HHS R01 AG021069NIA NIH HHS R01 AG022868NIA NIH HHS R01 AG024385NINDS NIH HHS NS 050789-01NINDS NIH HHS R03 NS050789
6 · The paper itself

Abstract

Lithium (Li(+)) has been used to treat mood affect disorders, including bipolar, for decades. This drug is neuroprotective and has several identified molecular targets. However, it has a narrow therapeutic range and the one or more underlying mechanisms of its therapeutic action are not understood. Here we describe a pharmacogenetic study of Li(+) in the nematode Caenorhabditis elegans. Exposure to Li(+) at clinically relevant concentrations throughout adulthood increases survival during normal aging (up to 46% median increase). Longevity is extended via a novel mechanism with altered expression of genes encoding nucleosome-associated functions. Li(+) treatment results in reduced expression of the worm ortholog of LSD-1 (T08D10.2), a histone demethylase; knockdown by RNA interference of T08D10.2 is sufficient to extend longevity ( approximately 25% median increase), suggesting Li(+) regulates survival by modulating histone methylation and chromatin structure.

Indexed as

AgingAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCell Line, TumorElectrophoresis, Polyacrylamide GelGene Expression Regulation, DevelopmentalGenome, HelminthGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansImmunohistochemistryLithium ChlorideLongevityOligonucleotide Array Sequence AnalysisRNA InterferenceCaenorhabditis elegans ProteinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaLithium Chloride

Identifiers

PMID17959600
PMCPMC2739662
OpenAlexW2007188652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.